HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Hilltop National Bank

Hilltop National Bank trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 10.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 383 shares of the company’s stock after selling 44 shares during the period. Hilltop National Bank’s holdings in HCA Healthcare were worth $115,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in HCA. Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare in the 2nd quarter valued at $33,000. Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare in the 3rd quarter valued at $39,000. Canoe Financial LP acquired a new stake in HCA Healthcare in the 3rd quarter valued at $41,000. Capital Performance Advisors LLP purchased a new position in HCA Healthcare in the 3rd quarter valued at about $41,000. Finally, Northwest Investment Counselors LLC purchased a new position in HCA Healthcare in the 3rd quarter valued at about $44,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Truist Financial reduced their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Finally, TD Cowen dropped their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Price Performance

NYSE HCA opened at $303.64 on Friday. HCA Healthcare, Inc. has a 12 month low of $276.50 and a 12 month high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm has a market capitalization of $76.91 billion, a PE ratio of 13.63, a P/E/G ratio of 1.21 and a beta of 1.64. The company’s 50 day simple moving average is $321.66 and its 200 day simple moving average is $353.61.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Insider Buying and Selling

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.